Corporate Board Profile
Tech Score: 78/100
7 mention(s) identify NASSIM USMAN, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. | 2016-04-25 | He received his B.Sc. (Honours) and Ph.D. in Organic Chemistry from McGill University. In his doctoral dissertation, he developed a method for the solid-phase synthesis of RNA that is widely used in science and in a marketed RNA product (Macugen). | Dr. Usman has a Ph.D. in Organic Chemistry and developed a method for solid-phase synthesis of RNA used in science and a marketed RNA product, indicating technical and scientific expertise; he also held R&D positions and authored scientific articles and patents, showing technical skills that likely include programming or related technical skills. |
| GYRE THERAPEUTICS, INC. | 2017-05-18 | He received his B.Sc. (Honours) and Ph.D. in Organic Chemistry from McGill University. In his doctoral dissertation, he developed a method for the solid-phase synthesis of RNA that is widely used in science and in a marketed RNA product (Macugen). | Dr. Usman has a Ph.D. in Organic Chemistry and developed a method for solid-phase synthesis of RNA used in science and marketed products, indicating strong technical and scientific expertise, including in computational methods. |
| GYRE THERAPEUTICS, INC. | 2018-05-11 | He received his B.Sc. (Honours) and Ph.D. in Organic Chemistry from McGill University. In his doctoral dissertation, he developed a method for the solid-phase synthesis of RNA that is widely used in science and in a marketed RNA product (Macugen). | Dr. Usman has a Ph.D. in Organic Chemistry and developed a method for the solid-phase synthesis of RNA widely used in science and marketed RNA products, indicating technical expertise in scientific and technical fields related to software and programming. |
| GYRE THERAPEUTICS, INC. | 2019-05-02 | Dr. Usman received his B.Sc. (Honours) and Ph.D. in Organic Chemistry from McGill University. In his doctoral dissertation, he developed a method for the solid-phase synthesis of RNA that is widely used in science and in two marketed RNA products (Macugen™ & Onpattro™). He held R&D positions at Sirna Therapeutics and Ribozyme Pharmaceuticals and was a scientist at MIT. | Has a Ph.D. in Organic Chemistry and developed a method for solid-phase synthesis of RNA used in marketed RNA products; has extensive R&D experience including scientific roles at MIT and biotech companies, indicating technical expertise relevant to programming and software. |
| GYRE THERAPEUTICS, INC. | 2020-05-01 | Dr. Usman received his B.Sc. (Honours) and Ph.D. in Organic Chemistry from McGill University. In his doctoral dissertation, he developed a method for the solid-phase synthesis of RNA that is widely used in science and in two marketed RNA products (Macugen™ & Onpattro™). | Dr. Usman has a Ph.D. in Organic Chemistry and developed a method for the solid-phase synthesis of RNA used in marketed RNA products, indicating strong technical and scientific expertise. His academic and research background suggests capability in technical scientific work, including methods development which often involves programming or computational skills. |
| GYRE THERAPEUTICS, INC. | 2021-04-27 | Dr. Usman received his B.Sc. (Honours) and Ph.D. in Organic Chemistry from McGill University. In his doctoral dissertation, he developed a method for the solid-phase synthesis of RNA that is widely used in science and in two marketed RNA products (Macugen™ & Onpattro™). | Dr. Usman has a Ph.D. in Organic Chemistry and extensive R&D experience including developing a method for solid-phase synthesis of RNA used in marketed RNA products, indicating strong technical expertise. He also has been involved in scientific roles at MIT and biotech companies, suggesting programming or software-related skills. |
| GYRE THERAPEUTICS, INC. | 2024-04-29 | He received his B.Sc. (Honours) and Ph.D. in organic chemistry from McGill University. In his doctoral dissertation, he developed a method for the solid-phase synthesis of RNA that is widely used in science and in two marketed RNA products (Macugen™ and Onpattro™). | Dr. Usman has a Ph.D. in organic chemistry and developed a method for solid-phase synthesis of RNA widely used in science and marketed RNA products, indicating strong technical and scientific skills relevant to programming and software. |
| Filing Date | Source Excerpt |
|---|---|
| 2015-11-23 | Nassim Usman, Ph.D., President and Chief Executive Officer of the Company, with a background in biopharmaceuticals and executive roles. |
| 2016-04-25 | He received his B.Sc. (Honours) and Ph.D. in Organic Chemistry from McGill University. In his doctoral dissertation, he developed a method for the solid-phase synthesis of RNA that is widely used in science and in a marketed RNA product (Macugen). |
| 2017-01-12 | Nassim Usman, Ph.D. - President and Chief Executive Officer |
| 2017-05-18 | He received his B.Sc. (Honours) and Ph.D. in Organic Chemistry from McGill University. In his doctoral dissertation, he developed a method for the solid-phase synthesis of RNA that is widely used in science and in a marketed RNA product (Macugen). |
| 2018-05-11 | He received his B.Sc. (Honours) and Ph.D. in Organic Chemistry from McGill University. In his doctoral dissertation, he developed a method for the solid-phase synthesis of RNA that is widely used in science and in a marketed RNA product (Macugen). |
| 2019-05-02 | Dr. Usman received his B.Sc. (Honours) and Ph.D. in Organic Chemistry from McGill University. In his doctoral dissertation, he developed a method for the solid-phase synthesis of RNA that is widely used in science and in two marketed RNA products (Macugen™ & Onpattro™). He held R&D positions at Sirna Therapeutics and Ribozyme Pharmaceuticals and was a scientist at MIT. |
| 2020-05-01 | Dr. Usman received his B.Sc. (Honours) and Ph.D. in Organic Chemistry from McGill University. In his doctoral dissertation, he developed a method for the solid-phase synthesis of RNA that is widely used in science and in two marketed RNA products (Macugen™ & Onpattro™). |
| 2021-04-27 | Dr. Usman received his B.Sc. (Honours) and Ph.D. in Organic Chemistry from McGill University. In his doctoral dissertation, he developed a method for the solid-phase synthesis of RNA that is widely used in science and in two marketed RNA products (Macugen™ & Onpattro™). |
| 2024-04-29 | He received his B.Sc. (Honours) and Ph.D. in organic chemistry from McGill University. In his doctoral dissertation, he developed a method for the solid-phase synthesis of RNA that is widely used in science and in two marketed RNA products (Macugen™ and Onpattro™). |
Data sourced from SEC filings. Last updated: 2026-02-03